Cargando…

Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma Using Convolutional Neural Network of Tumor Center (18)F-FDG PET Images

We compared the accuracy of prediction of the response to neoadjuvant chemotherapy (NAC) in osteosarcoma patients between machine learning approaches of whole tumor utilizing fluorine−(18)fluorodeoxyglucose ((18)F-FDG) uptake heterogeneity features and a convolutional neural network of the intratumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jingyu, Jeong, Su Young, Kim, Byung-Chul, Byun, Byung-Hyun, Lim, Ilhan, Kong, Chang-Bae, Song, Won Seok, Lim, Sang Moo, Woo, Sang-Keun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617812/ https://www.ncbi.nlm.nih.gov/pubmed/34829324 http://dx.doi.org/10.3390/diagnostics11111976

Ejemplares similares

Early response monitoring of neoadjuvant chemotherapy using [(18)F]FDG PET can predict the clinical outcome of extremity osteosarcoma
por: Lee, Inki, et al.
Publicado: (2020)

Preliminary Radiogenomic Evidence for the Prediction of Metastasis and Chemotherapy Response in Pediatric Patients with Osteosarcoma Using (18)F-FDG PET/CT, EZRIN, and KI67
por: Kim, Byung-Chul, et al.
Publicado: (2021)

Prediction of Chemotherapy Response of Osteosarcoma Using Baseline (18)F-FDG Textural Features Machine Learning Approaches with PCA
por: Jeong, Su Young, et al.
Publicado: (2019)

Comparison of (99m)Tc-methyl diphosphonate bone scintigraphy and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography to predict histologic response to neoadjuvant chemotherapy in patients with osteosarcoma
por: Lee, Inki, et al.
Publicado: (2018)

Deep Learning-Based Delayed PET Image Synthesis from Corresponding Early Scanned PET for Dosimetry Uptake Estimation
por: Kim, Kangsan, et al.
Publicado: (2023)

Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning
por: Choi, Joon Ho, et al.
Publicado: (2020)

The role of (18)F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using (131)I-rituximab as consolidation therapy
por: Choi, Joon Ho, et al.
Publicado: (2022)

Metastasis risk prediction model in osteosarcoma using metabolic imaging phenotypes: A multivariable radiomics model
por: Sheen, Heesoon, et al.
Publicado: (2019)

Characteristics of thyroid incidentalomas detected by pre-treatment [(18)F]FDG PET or PET/CT in patients with cervical cancer
por: Lee, Won-Moo, et al.
Publicado: (2012)

Development and External Validation of (18)F-FDG PET-Based Radiomic Model for Predicting Pathologic Complete Response after Neoadjuvant Chemotherapy in Breast Cancer
por: Lim, Chae Hong, et al.
Publicado: (2023)

Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma
por: Hwang, Jae Pil, et al.
Publicado: (2016)

Estimation of an Image Biomarker for Distant Recurrence Prediction in NSCLC Using Proliferation-Related Genes
por: Ju, Hye Min, et al.
Publicado: (2023)

Early Assessment of Response to Neoadjuvant Chemotherapy with (18)F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
por: Chung, Young Shin, et al.
Publicado: (2020)

Detection of Recurrence by (18)F-FDG PET in Patients with Endometrial Cancer Showing No Evidence of Disease
por: Ryu, Sang-Young, et al.
Publicado: (2010)

The Prediction of HER2-Targeted Treatment Response Using (64)Cu-Tetra-Azacyclododecanetetra-Acetic Acid (DOTA)-Trastuzumab PET/CT in Metastatic Breast Cancer: A Case Report
por: Lee, Inki, et al.
Publicado: (2022)

Benign Colonic (18)F-FDG Uptake on Whole-Body FDG-PET Scan
por: Jang, Byung Ik
Publicado: (2012)

Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using (18)F-FDG PET
por: Yoon, Joon-Kee, et al.
Publicado: (2019)

Metabolic activity of extranodal NK/T cell lymphoma on (18)F-FDG PET/CT according to immune subtyping
por: Lim, Chae Hong, et al.
Publicado: (2021)

Early Interim Chemotherapy Response Evaluation by F-18 FDG PET/CT in Diffuse Large B Cell Lymphoma
por: Park, Hye Lim, et al.
Publicado: (2020)

Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer
por: Bae, Ja Seong, et al.
Publicado: (2009)

The correlation of neuropsychological evaluation with (11)C-PiB and (18)F-FC119S amyloid PET in mild cognitive impairment and Alzheimer disease
por: Park, Su Yeon, et al.
Publicado: (2020)

A preliminary clinical trial to evaluate (64)Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer
por: Lee, Inki, et al.
Publicado: (2021)

Falsely Negative F-18 FDG PET of Osteosarcoma Arising In Paget Disease
por: Bush, Lisabeth Ann, et al.
Publicado: (2015)

Prognostic value of complete metabolic response on (18)F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer
por: Chung, Young Shin, et al.
Publicado: (2022)

The Effect of Xanthigen on the Expression of Brown Adipose Tissue Assessed by (18)F-FDG PET
por: Kim, Kwang-Min, et al.
Publicado: (2016)

(18)F-FDG PET versus (18)F-FDG PET/CT for Adrenal Gland Lesion Characterization: a Comparison of Diagnostic Efficacy in Lung Cancer Patients
por: Sung, Yon Mi, et al.
Publicado: (2008)

Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder Cancer
por: Hwang, Jae Pil, et al.
Publicado: (2013)

Visualization of Synthetic Vascular Smooth Muscle Cells in Atherosclerotic Carotid Rat Arteries by F-18 FDG PET
por: Pahk, Kisoo, et al.
Publicado: (2017)

Metabolic Super Scan in (18)F-FDG PET/CT Imaging
por: Kim, Dae-Weung, et al.
Publicado: (2010)

Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma
por: Bailly, Clement, et al.
Publicado: (2017)

Complementarity between (18)F-FDG PET/CT and Ultrasonography or Angiography in Carotid Plaque Characterization
por: Noh, Sang-Mi, et al.
Publicado: (2013)

Selective neurodegeneration of the hippocampus caused by chronic cerebral hypoperfusion: F-18 FDG PET study in rats
por: Lee, Jung-In, et al.
Publicado: (2022)

Diagnostic accuracy of (18)F-FDG PET/CT for detecting synchronous advanced colorectal neoplasia in patients with gastric cancer
por: Choi, Byung Wook, et al.
Publicado: (2016)

Post-reconstruction enhancement of [(18)F]FDG PET images with a convolutional neural network
por: Ly, John, et al.
Publicado: (2021)

Role of F-18 FDG PET/CT in non-conjunctival origin ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphomas
por: Park, Hye Lim, et al.
Publicado: (2019)

Monitoring tumor response to neoadjuvant chemotherapy using MRI and (18)F-FDG PET/CT in breast cancer subtypes
por: Schmitz, Alexander M. Th., et al.
Publicado: (2017)

Predicting Response to Neoadjuvant Chemotherapy Using 18F FDG PET-CT in Patients with Locally Advanced Breast Cancer
por: Hulikal, Narendra, et al.
Publicado: (2020)

(18)F-FDG PET/CT in Primary AL Hepatic Amyloidosis Associated with Multiple Myeloma
por: Son, Youn Mi, et al.
Publicado: (2011)

18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy
por: Capelli, Giulia, et al.
Publicado: (2022)

Striatofrontal Deafferentiation in MSA-P: Evaluation with [(18)F]FDG Brain PET
por: Kim, Hae Won, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8avsaue19ppkrr3fc2815s64ir